DI CICILIA, ROBERTO
DI CICILIA, ROBERTO
DIPARTIMENTO DI EMATOLOGIA E SCIENZE ONCOLOGICHE "L. e A. SERAGNOLI"
R.DICICILIA; DI CICILIA R
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases
2011 Di Marco M; Macchini M; Vecchiarelli S; Casadei R; Pezzilli R; Fanti S; Zanoni L; Calculli L; Barbieri E; Santini D; DI Cicilia R; Brandi G; Biasco G.
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment?
2010 Di Marco M; Di Cicilia R; Macchini M; Nobili E; Vecchiarelli S; Brandi G; Biasco G
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study
2010 M. Di Marco; M. Macchini; R. di Cicilia; S. Vecchiarelli; R. Casadei; E. Barbieri; L. Calculli; M. A. Pantaleo; G. Biasco
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action
2010 Macchini M; Brandi G; Tavolari S; Guarnieri T; de Rosa F; Paterini P; Di Girolamo S; Agostini V; Di Marco M; Vecchiarelli S; Di Cicilia R; Nobili E; Biasco G.
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience.
2010 Nobili E; Di Cicilia R; Di Battista M; Morselli-Labate AM; Paragona M; Corbelli J; Macchini M; Prandoni P; Biasco G; Brandi G.
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment?
2009 Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G.
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment?
2009 Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G.
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC)
2009 Brandi, Giovanni; Paterini, Paola; Tavolari, Simona; dal Pozzo, G.; Nobili, Elisabetta; DI CICILIA, Roberto; DI MARCO, Mariacristina; Pantaleo, MARIA ABBONDANZA; DE ROSA, Francesco; Biasco, Guido
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients.
2009 Macchini M; Di Cicilia R; Vecchiarelli S; de Rosa F; Nobili E; Di Marco M; Biasco G.
The protease inhibitor gabexate Mesylate has antitumor effects and enhances gemcitabine action on pancreatic cancer cell lines
2009 Brandi G; tavolari S; Paterini P; de Rosa F; Di Girolamo S; Agostini V;Di Cicilia R;Di Marco M; Nobili E; Biasco G.
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean
2008 G. Brandi;R Di Cicilia;M.Di Battista;E.Nobili;M.Astorino;M. Di Marco;MA Pantaleo;G.Biasco
EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN
2008 G. BRANDI;E. NOBILI; E.CAPIZZI;B. CORTI; R. DI CICILIA; M. DI MARCO;G. BIASCO
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE
2008 M.Di Marco ;M. Macchini; R. Di Cicilia ; E. Nobili ; G. Biasco
Gemox in combination witherlotinib (E) in pancreatic cancer (PC).
2008 R. Di Cicilia;M. Macchini; M. Di Marco;E. Nobili;L.Calculli;R. Casadei; G.Biasco
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases |
Di Marco M; Macchini M; Vecchiarelli S; Casadei R; Pezzilli R; Fanti S; Zanoni L; Calculli L; Ba...rbieri E; Santini D; DI Cicilia R; Brandi G; Biasco G. |
2011-01-01 | ONCOLOGY LETTERS | - | 1.01 Articolo in rivista | - |
| Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? |
Di Marco M; Di Cicilia R; Macchini M; Nobili E; Vecchiarelli S; Brandi G; Biasco G |
2010-01-01 | ONCOLOGY REPORTS | - | 1.01 Articolo in rivista | - |
| Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study | M. Di Marco; M. Macchini; R. di Cicilia; S. Vecchiarelli; R. Casadei; E. Barbieri; L. Calculli; M.... A. Pantaleo; G. Biasco | 2010-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action | Macchini M; Brandi G; Tavolari S; Guarnieri T; de Rosa F; Paterini P; Di Girolamo S; Agostini V; ...Di Marco M; Vecchiarelli S; Di Cicilia R; Nobili E; Biasco G. | 2010-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
| Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. | Nobili E; Di Cicilia R; Di Battista M; Morselli-Labate AM; Paragona M; Corbelli J; Macchini M; Pr...andoni P; Biasco G; Brandi G. | 2010-01-01 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | - | 1.01 Articolo in rivista | - |
| Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? | Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G. | 2009-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? | Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G. | 2009-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
| Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) | Brandi, Giovanni; Paterini, Paola; Tavolari, Simona; dal Pozzo, G.; Nobili, Elisabetta; DI CICILI...A, Roberto; DI MARCO, Mariacristina; Pantaleo, MARIA ABBONDANZA; DE ROSA, Francesco; Biasco, Guido | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. | Macchini M; Di Cicilia R; Vecchiarelli S; de Rosa F; Nobili E; Di Marco M; Biasco G. | 2009-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
| The protease inhibitor gabexate Mesylate has antitumor effects and enhances gemcitabine action on pancreatic cancer cell lines | Brandi G; tavolari S; Paterini P; de Rosa F; Di Girolamo S; Agostini V;Di Cicilia R;Di Marco M; N...obili E; Biasco G. | 2009-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean | G. Brandi;R Di Cicilia;M.Di Battista;E.Nobili;M.Astorino;M. Di Marco;MA Pantaleo;G.Biasco | 2008-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN | G. BRANDI;E. NOBILI; E.CAPIZZI;B. CORTI; R. DI CICILIA; M. DI MARCO;G. BIASCO | 2008-01-01 | PANCREAS | - | 1.01 Articolo in rivista | - |
| GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE | M.Di Marco ;M. Macchini; R. Di Cicilia ; E. Nobili ; G. Biasco | 2008-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Gemox in combination witherlotinib (E) in pancreatic cancer (PC). | R. Di Cicilia;M. Macchini; M. Di Marco;E. Nobili;L.Calculli;R. Casadei; G.Biasco | 2008-01-01 | JOP. JOURNAL OF THE PANCREAS | s.n | 4.02 Riassunto (Abstract) | - |